Monogram Financial Statements From 2010 to 2024

MGRM Stock   2.25  0.05  2.27%   
Monogram Orthopaedics financial statements provide useful quarterly and yearly information to potential Monogram Orthopaedics Common investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Monogram Orthopaedics financial statements helps investors assess Monogram Orthopaedics' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Monogram Orthopaedics' valuation are summarized below:
Market Capitalization
77.2 M
Enterprise Value Revenue
167.2298
Revenue
365 K
Earnings Share
(0.47)
Revenue Per Share
0.012
There are over one hundred nineteen available fundamental ratios for Monogram Orthopaedics, which can be analyzed over time and compared to other ratios. Self-guided Investors are advised to check Monogram Orthopaedics' last-minute fundamentals against the trend between 2010 and 2024 to make sure the company can sustain itself down the road. As of the 8th of December 2024, Enterprise Value is likely to drop to about 60.8 M

Monogram Orthopaedics Total Revenue

356,728

Check Monogram Orthopaedics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Monogram Orthopaedics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 433 K, Interest Expense of 18.5 K or Selling General Administrative of 4.3 M, as well as many indicators such as Price To Sales Ratio of 417, Dividend Yield of 0.0 or PTB Ratio of 6.04. Monogram financial statements analysis is a perfect complement when working with Monogram Orthopaedics Valuation or Volatility modules.
  
Check out the analysis of Monogram Orthopaedics Correlation against competitors.

Monogram Orthopaedics Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets17.4 M16.6 M4.8 M
Slightly volatile
Short and Long Term Debt Total777 K492 K973.6 K
Pretty Stable
Other Current Liabilities216.3 K227.7 K1.1 M
Slightly volatile
Total Current LiabilitiesM2.8 MM
Slightly volatile
Property Plant And Equipment Net765.2 K1.4 M440.1 K
Slightly volatile
Accounts Payable2.6 M2.5 M475 K
Slightly volatile
Cash14.3 M13.6 M3.6 M
Slightly volatile
Non Current Assets Total1.4 MM753.5 K
Slightly volatile
Cash And Short Term Investments14.3 M13.6 M3.6 M
Slightly volatile
Common Stock Shares Outstanding23 M22.4 M29.4 M
Slightly volatile
Liabilities And Stockholders Equity17.4 M16.6 M4.8 M
Slightly volatile
Non Current Liabilities Total274 K363.7 K646.6 K
Slightly volatile
Other Stockholder Equity68.1 M64.9 M14.8 M
Slightly volatile
Total Liabilities4.3 M3.2 M2.6 M
Slightly volatile
Total Current Assets15.3 M14.6 MM
Slightly volatile
Common Stock32.9 K31.3 K6.6 K
Slightly volatile
Short Term Debt121.9 K128.3 K1.3 M
Slightly volatile
Current Deferred Revenue0.951.0289.3 K
Very volatile
Long Term Debt38.4 K43.2 K47 K
Slightly volatile
Other Current Assets551.2 K664.3 K242.8 K
Slightly volatile
Net Invested Capital14.1 M13.4 M3.9 M
Slightly volatile
Property Plant And Equipment Gross1.4 M2.1 M695.9 K
Slightly volatile
Short and Long Term Debt1.7 M1.9 MM
Slightly volatile
Capital Stock18.8 K31.3 K10 K
Slightly volatile
Property Plant Equipment1.3 M1.9 M666.8 K
Slightly volatile
Non Currrent Assets Other176.2 K167.8 K41.6 K
Slightly volatile
Capital Lease Obligations417.8 K492 K266.1 K
Slightly volatile
Intangible Assets808 K548.8 K781.7 K
Slightly volatile
Net Receivables251 K365 K386.4 K
Slightly volatile
Inventory0.951.0447.8 K
Slightly volatile
Non Current Liabilities Other0.80.90.98
Slightly volatile
Other Liabilities0.80.90.98
Slightly volatile

Monogram Orthopaedics Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization433 K412.3 K121.3 K
Slightly volatile
Interest Expense18.5 K19.5 K34.1 K
Pretty Stable
Selling General Administrative4.3 M4.1 M1.4 M
Slightly volatile
Selling And Marketing Expenses1.6 MM805.2 K
Slightly volatile
Other Operating Expenses18.5 M17.6 M4.8 M
Slightly volatile
Research Development11.1 M10.6 M2.5 M
Slightly volatile
Total Operating Expenses18.5 M17.6 M4.7 M
Slightly volatile
Interest Income258 K245.7 K55.3 K
Slightly volatile
Cost Of Revenue304.7 K412.3 K131.7 K
Slightly volatile
Reconciled Depreciation273.7 K408 K120.2 K
Slightly volatile

Monogram Orthopaedics Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation969.2 K1.6 M458.2 K
Slightly volatile
Depreciation433 K412.3 K121.3 K
Slightly volatile
Capital Expenditures61.7 K64.9 K272 K
Pretty Stable
Total Cash From Financing Activities8.7 M16.7 M4.7 M
Slightly volatile
End Period Cash Flow14.3 M13.6 M3.6 M
Slightly volatile
Begin Period Cash Flow11 M10.5 M2.5 M
Slightly volatile
Issuance Of Capital Stock12.3 M18.7 MM
Slightly volatile
Change To NetincomeM4.8 M1.6 M
Slightly volatile
Sale Purchase Of Stock198.4 K223.2 K243 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio417243496
Slightly volatile
Days Sales Outstanding195219238
Slightly volatile
Average Payables197.8 K284.3 K207.2 K
Slightly volatile
Stock Based Compensation To Revenue4.043.841.0719
Slightly volatile
Capex To Depreciation0.150.15747.597
Slightly volatile
EV To Sales393202482
Slightly volatile
Inventory Turnover80.3176.4916.775
Slightly volatile
Days Of Inventory On Hand4.694.94357
Slightly volatile
Payables Turnover0.390.520.5116
Very volatile
Sales General And Administrative To Revenue5.659.994.1983
Slightly volatile
Average Inventory224.7 K253.8 K274.5 K
Slightly volatile
Research And Ddevelopement To Revenue14.9626.111.3927
Slightly volatile
Capex To Revenue0.190.21.319
Slightly volatile
Cash Per Share0.640.60640.1436
Slightly volatile
Days Payables Outstanding684720978
Pretty Stable
Income Quality0.560.98530.8044
Slightly volatile
Intangibles To Total Assets0.03140.03310.0843
Pretty Stable
Current Ratio5.455.18713.7303
Slightly volatile
Receivables Turnover1.21.351.471
Slightly volatile
Graham Number3.022.87240.689
Slightly volatile
Capex Per Share0.00280.00290.0092
Pretty Stable
Average Receivables202.3 K261.3 K217.5 K
Slightly volatile
Revenue Per Share0.02080.01870.0209
Slightly volatile
Interest Debt Per Share8.0E-49.0E-40.028
Slightly volatile
Debt To Assets0.890.931.8901
Slightly volatile
Days Of Payables Outstanding684720978
Pretty Stable
Ebt Per Ebit1.230.7961.099
Pretty Stable
Total Debt To Capitalization2.591.322.397
Slightly volatile
Quick Ratio5.455.18713.723
Slightly volatile
Cash Ratio5.064.82193.6412
Slightly volatile
Days Of Inventory Outstanding4.694.94357
Slightly volatile
Days Of Sales Outstanding195219238
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.281.00481.2092
Slightly volatile
Fixed Asset Turnover0.280.30.7789
Slightly volatile
Debt Ratio0.890.931.8901
Slightly volatile
Price Sales Ratio417243496
Slightly volatile
Asset Turnover0.02410.02530.0624
Slightly volatile
Gross Profit Margin0.220.240.2646
Slightly volatile
Operating Cycle551619675
Slightly volatile
Cash Conversion Cycle265298324
Slightly volatile

Monogram Orthopaedics Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap73.2 M77.1 M319.6 M
Slightly volatile
Enterprise Value60.8 M64 M317.1 M
Slightly volatile

Monogram Fundamental Market Drivers

Cash And Short Term Investments13.6 M

Monogram Upcoming Events

14th of February 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

About Monogram Orthopaedics Financial Statements

Monogram Orthopaedics investors utilize fundamental indicators, such as revenue or net income, to predict how Monogram Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue 1.00  0.95 
Total Revenue365 K356.7 K
Cost Of Revenue412.3 K304.7 K
Stock Based Compensation To Revenue 3.84  4.04 
Sales General And Administrative To Revenue 9.99  5.65 
Research And Ddevelopement To Revenue 26.10  14.96 
Capex To Revenue 0.20  0.19 
Revenue Per Share 0.02  0.02 
Ebit Per Revenue(54.41)(57.13)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Monogram Orthopaedics is a strong investment it is important to analyze Monogram Orthopaedics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Monogram Orthopaedics' future performance. For an informed investment choice regarding Monogram Stock, refer to the following important reports:
Check out the analysis of Monogram Orthopaedics Correlation against competitors.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Monogram Orthopaedics. If investors know Monogram will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Monogram Orthopaedics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.47)
Revenue Per Share
0.012
Return On Assets
(0.61)
Return On Equity
(1.22)
The market value of Monogram Orthopaedics is measured differently than its book value, which is the value of Monogram that is recorded on the company's balance sheet. Investors also form their own opinion of Monogram Orthopaedics' value that differs from its market value or its book value, called intrinsic value, which is Monogram Orthopaedics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Monogram Orthopaedics' market value can be influenced by many factors that don't directly affect Monogram Orthopaedics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Monogram Orthopaedics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Monogram Orthopaedics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Monogram Orthopaedics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.